Alkem Laboratories Limited (ALKEM) — Capital Reinvestment Ratio
Alkem Laboratories Limited (ALKEM) has a Capital Reinvestment Ratio of 0.47x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs8.37 Billion) in capital expenditures (Rs3.96 Billion). See ALKEM net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Alkem Laboratories Limited Capital Reinvestment Ratio (2011–2025)
This chart tracks Alkem Laboratories Limited's Capital Reinvestment Ratio across 15 annual periods. Check ALKEM total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Alkem Laboratories Limited (2011–2025)
Year-by-year Capital Reinvestment Ratio for Alkem Laboratories Limited from 2011 to 2025. For live market cap and broader valuation context, see ALKEM market cap overview.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.35x | Rs19.13 Billion | Rs6.76 Billion | ▲ +165.4% |
| 2024 | 0.13x | Rs19.48 Billion | Rs2.59 Billion | ▼ -3.9% |
| 2023 | 0.14x | Rs16.82 Billion | Rs2.33 Billion | ▼ -54.6% |
| 2022 | 0.31x | Rs11.11 Billion | Rs3.39 Billion | ▲ +97.9% |
| 2021 | 0.15x | Rs12.65 Billion | Rs1.95 Billion | ▼ -75.2% |
| 2020 | 0.62x | Rs5.85 Billion | Rs3.63 Billion | ▼ -8.8% |
| 2019 | 0.68x | Rs7.77 Billion | Rs5.29 Billion | ▼ -72.5% |
| 2018 | 2.48x | Rs2.76 Billion | Rs6.84 Billion | ▲ +80.9% |
| 2017 | 1.37x | Rs4.71 Billion | Rs6.45 Billion | ▲ +286.2% |
| 2016 | 0.35x | Rs7.26 Billion | Rs2.57 Billion | ▼ -16.5% |
| 2015 | 0.42x | Rs3.25 Billion | Rs1.38 Billion | ▲ +18.7% |
| 2014 | 0.36x | Rs2.90 Billion | Rs1.04 Billion | ▼ -74.5% |
| 2013 | 1.40x | Rs1.56 Billion | Rs2.20 Billion | ▼ -20.5% |
| 2012 | 1.77x | Rs1.18 Billion | Rs2.09 Billion | ▲ +1163.0% |
| 2011 | 0.14x | Rs8.38 Billion | Rs1.17 Billion | — |